Continuous Glucose Monitoring During Basal–Bolus Therapy Using Insulin Glargine 300 U mL(−1) and Glargine 100 U mL(−1) in Japanese People with Type 1 Diabetes Mellitus: A Crossover Pilot Study

INTRODUCTION: New insulin glargine 300 U mL(−1) (Gla-300) is a basal insulin that shows more stable and prolonged pharmacokinetic and pharmacodynamic profiles than insulin glargine 100 U mL(−1) (Gla-100). This study used continuous glucose monitoring (CGM) to compare 24-h glucose profiles in a Japan...

Descripción completa

Detalles Bibliográficos
Autores principales: Jinnouchi, Hideaki, Koyama, Masayoshi, Amano, Atsushi, Takahashi, Yoshinori, Yoshida, Akira, Hieshima, Kunio, Sugiyama, Seigo, Kurinami, Noboru, Jinnouchi, Tomio, Becker, Reinhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478173/
https://www.ncbi.nlm.nih.gov/pubmed/26055218
http://dx.doi.org/10.1007/s13300-015-0115-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478173/
https://www.ncbi.nlm.nih.gov/pubmed/26055218
http://dx.doi.org/10.1007/s13300-015-0115-1

Ejemplares similares